Synairgen plc (LON:SNG – Get Free Report) shares passed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of GBX 4.94 ($0.06) and traded as low as GBX 4.60 ($0.06). Synairgen shares last traded at GBX 4.77 ($0.06), with a volume of 129,781 shares changing hands.
Synairgen Stock Up 5.9 %
The company has a quick ratio of 6.35, a current ratio of 6.77 and a debt-to-equity ratio of 0.09. The company has a market capitalization of £9.60 million, a PE ratio of -158.83 and a beta of -2.23. The firm has a 50-day moving average of GBX 4.03 and a two-hundred day moving average of GBX 4.94.
About Synairgen
Synairgen plc discovers and develops drugs for respiratory diseases. It develops SNG001, an inhaled interferon beta for the treatment of COVID-19; inhaled interferon beta (IFN-ß), which is in Phase-II clinical trials for the treatment of asthma caused by the common cold and flu; and IFN-ß that is in Phase-II clinical trials for the treatment or prevention of chronic obstructive pulmonary disease.
See Also
- Five stocks we like better than Synairgen
- The How And Why of Investing in Oil Stocks
- Energy Vault Soars 100%: CEO Shares Why in MarketBeat Exclusive
- Stock Dividend Cuts Happen Are You Ready?
- Meta’s Q3 Earnings Beat—Is This Dip a Golden Entry Opportunity?
- Investing in the High PE Growth Stocks
- Top Nuclear Stocks Thriving on Soaring Energy Demand
Receive News & Ratings for Synairgen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synairgen and related companies with MarketBeat.com's FREE daily email newsletter.